An emerging global leader in cancer treatment

Sirtex Medical Limited is an Australian company with an approved cancer treatment supplied globally. Sirtex's main commercialised product is a targeted radioactive treatment for liver cancer called SIR-Spheres® Y-90 resin microspheres.

Over 92,000 doses of SIR-Spheres Y-90 resin microspheres have been supplied to treat liver cancer patients at over 1,230 medical centres in over 40 countries.

This product has PMA approval from the U.S. Food & Drug Administration (FDA), the European Union (CE Mark) and Australia's Therapeutic Goods Administration (TGA).

Sirtex has manufacturing capabilities in the U.S., Singapore and Germany.

What are SIR-Spheres Y-90 resin microspheres and how are they used?

SIR-Spheres Y-90 resin microspheres are used to deliver targeted internal radiation therapy directly to liver tumours via the hepatic artery.

This therapy is called Selective Internal Radiation Therapy (SIRT) and is performed using minimally invasive surgical techniques by an interventional radiologist.

Where SIR-Spheres Y-90 resin microspheres are used, the available clinical evidence suggests SIR-Spheres Y-90 resin microspheres may approximately double the rate of tumour shrinkage and tumour remission.

The evidence also suggests it may be capable of improving the life expectancy of patients.

2017 Full year financial and operating highlights

  • 13 consecutive years of growth
  • Dose sales of 12,578, up 5.4 per cent
  • Revenues of $234.3 million, up 0.8 per cent
  • Underlying net profit after tax of $42.4 million, down 20.9 per cent
  • Reported net loss after tax of $26.3 million, down 149.0 per cent
  • Cash balance of $118.3 million, up 10.6 per cent and no debt
  • Underlying earnings per share of 73.5 cents, down 21.6 per cent
  • Reported earnings per share of -45.5 cents, down 148.6 per cent
  • Dividend per share of 30 cents, up 0 per cent

Now leaving

You are about to leave the Sirtex Web site. This link is provided to you as a service and will take you to a site maintained by a third party who is solely responsible for the content.

Please be aware that Sirtex takes no responsibility for content of these external sites, nor do we endorse, warrant or guarantee the products, services or information described or offered on other internet sites.

Click 'Continue' to proceed to the third-party Web site.



You are now leaving your current region

The Sirtex site you are linking to is intended only for healthcare practitioners and patients outside your current region. Any products discussed herein may have different approved product labeling; therefore, any information provided may not be appropriate for use in your region.

Click 'Continue' to proceed to the other Sirtex region Web site.